CA
Insider
Christopher Richard Anzalone
Chief Executive OfficerChristopher Richard Anzalone (Chief Executive Officer) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Arrowhead Pharmaceuticals, Inc. (ARWR). The largest single filing was $12.2M of ARWR (181,832 sh across 9 lots, as filed), executed Dec 15 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
5
0 buys · 5 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$23.7M
shares × price, as filed
Last traded
Jan 2
Filed Jan 5
Median ADV $181.7M across their filed names
Open performance→Volume by month
Buys $0
Sells $32.3M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
5 filings
Sector per market data · by filing · past 12 months
Most traded names
ARWRRecent filings
ARWRSALE
Arrowhead Pharmaceuticals, Inc.
View filing →
$219K11,520 sh × $19.05
Exec Jan 2 2025
Filed Jan 6 2025 · 5:30 PM ET ARWRSALE Arrowhead Pharmaceuticals, Inc. View filing → $246K
12,563 sh × $19.59
Exec Dec 23 2024
Filed Dec 23 2024 · 5:30 PM ET ARWRSALE Arrowhead Pharmaceuticals, Inc. View filing → $567K
26,712 sh across 3 lots
Exec Dec 18 2024
Filed Dec 20 2024 · 5:30 PM ET